HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/5/R1839    most recent 00755.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Singleton, K. D. Articles by Wischmeyer, P. E. Search for Related Content PubMed PubMed Citation Articles by Singleton, K. D. Articles by Wischmeyer, P. E.

INFLAMMATION AND CYTOKINES

Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression

Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, Colorado

Submitted 30 October 2006 ; accepted in final form 9 January 2007

Glutamine (GLN) has been shown to protect against inflammatory injury and illness in experimental and clinical settings. The mechanism of this protection is unknown; however, laboratory and clinical trial data have indicated a relationship between GLN-mediated protection and enhanced heat shock protein 70 (HSP70) expression. The aim of this study was to examine the hypothesis that GLN's beneficial effect on survival, tissue injury, and inflammatory response after inflammatory injury is dependent on HSP70 expression. Mice with a specific deletion of the HSP70 gene underwent cecal ligation and puncture (CLP)-induced sepsis and were treated with GLN (0.75 g/kg) or a saline placebo 1 h post-CLP. Lung tissue NF-B activation, inflammatory cytokine response, and lung injury were assessed post-CLP. Survival was assessed for 5 days post-CLP. Our results indicate that GLN administration improved survival in Hsp70^+/+ mice vs. Hsp70^+/+ mice not receiving GLN; however, GLN exerted no survival benefit in Hsp70^–/– mice. This was accompanied by a significant decrease in lung injury, attenuation of NF-B activation, and proinflammatory cytokine expression in GLN-treated Hsp70^+/+ mice vs. Hsp70^+/+ mice not receiving GLN. In the Hsp70^–/– mice, GLN's attenuation of lung injury, NF-B activation, and proinflammatory cytokine expression was lost. These results confirm our hypothesis that HSP70 expression is required for GLN's effects on survival, tissue injury, and the inflammatory response after global inflammatory injury.

inflammation; NF-B; Hsp70.1 and Hsp70.3 genes; cecal ligation and puncture

This article has been cited by other articles:

				P. E. Wischmeyer Glutamine in acute lung injury: the experimental model matters Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L286 - L287. [Full Text] [PDF]

				E. K. Robinson, D. P. Kelly, D. W. Mercer, and R. A. Kozar Differential Effects of Luminal Arginine and Glutamine on Metalloproteinase Production in the Postischemic Gut JPEN J Parenter Enteral Nutr, July 1, 2008; 32(4): 433 - 438. [Abstract] [Full Text] [PDF]